Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06283095
NCT06283095RecruitingNot Applicable

Management of Obstructive Sleep Apnea Syndrome by Expansion Palatoplasty

ET Zarief1 site in 1 country30 target enrollmentStarted: November 1, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Evaluation the outcome of expansion palatoplasty in management of OSAS.
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The study will be conducted to evaluate the outcome of expansion palatoplasty in management of OSAS.

Detailed Description

Expansion palatopladty will be conducted on patients with obstructive sleep apnea patients to evaluate the outcome.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients.
  • •Body mass index < 30 kg/m2 (weight /height in m2)
  • •Mild to moderate OSAS
  • •Sagittal collapse of the lateral pharyngeal walls proved by Drug induced sleep endoscopy (DISE).

Exclusion Criteria

  • •• Refusing enrollment into the study.
  • •Pregnant women.
  • •Refusing the surgery
  • •Contraindication to anaesthesia
  • •Patients with multilevel of obstruction.
  • •Serious psychiatric, neurological and cardiopulmonary (COPD or corpulmonale) diseases.
  • •Uncorrected hypothyroidism.
  • •Severe OSAS.
  • •Craniofacial anamolies.
  • •Central& mixed apnea
  • •Morbid obesity.

Arms & Interventions

study group

Experimental

we will do expansion palatoplasty

Intervention: expansion palatoplasty (Procedure)

Outcomes

Primary Outcomes

Evaluation the outcome of expansion palatoplasty in management of OSAS.

Time Frame: Six months

Polysomngrophy

Secondary Outcomes

  • Expansion palatoplasty in Obstructive sleep apnea patients(Six months)

Investigators

Sponsor
ET Zarief
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

ET Zarief

Principle investigator

Assiut University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Management of Obstructive Sleep Apnea (OSA) in Children and Maxillary and Mandibular DevelopmentObstructive Sleep Apnea Syndrome
NCT03267927Rennes University Hospital4
Completed
Not Applicable
MyOSA : Management and Treatment of Patients With Obstructive Sleep Apnea Syndrome(OSAS) Through a Telemedicine SystemSleep Apnea Syndrome
NCT03116958Sociedad Española de Neumología y Cirugía Torácica60
Completed
Not Applicable
PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular FunctionSleep Apnea, ObstructiveArteriosclerosis of Coronary Artery Bypass Graft or Other Coronary ReperfusionHeart Failure
NCT01900379University Hospital, Grenoble17
Completed
Not Applicable
Dental Device for Treatment of Sleep ApneaSleep Apnea Syndromes
NCT01005940Ulysses Magalang MD20
Completed
Phase 4
Effects of Obstructive Sleep Apnea Treatment by Fixed CPAP and by Auto-CPAP (Somnosmart2)Obstructive Sleep Apnea Syndrome
NCT00633711Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy17